||| venerdì, 23 Ottobre 2026 |||

Suggerimenti

0
0
Tag

EN65361

Bridge to Life™ Secures FDA De Novo Clearance for VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System, the First Device Cleared in the U.S. for Hypothermic Oxygenated Perfusion of Donor Livers

FDA-cleared labeling supports broad clinical applicability, including Donation after Circulatory Death (DCD) donors, and positions VitaSmart™ as a scalable and economically compelling platform for U.S. transplant centers  DULUTH, Ga., Jan. 20, 2026 /PRNewswire/ — Bridge to Life™ Ltd., a global
Leggi tutto

Sponsor